Although I think there could be more downside to the name, it is prudent to book gains given the ~50% return, which at ~$4 per share, which was better than my original $5.2 price target (notably did not include the Allstate loss). Finally, on the long side I wouldn't want to get involved with Mar...
![](https://sumzero-prod.s3.amazonaws.com/public/uploads/blog_post/featured_MCHX_92a2d984b4.png)
Marchex Case Is a Prelude to Bigger Shorts to Come
Published: October 02, 2014